REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

Clinical trials for REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY trials appear

Sign up with your email to follow new studies for REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for stubborn nerve disorder? drug combo tested in 76 patients

Disease control Ongoing

This study tests whether adding telitacicept to standard treatment helps people with refractory chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disease that causes weakness and numbness. About 76 adults aged 18-65 will receive either standard care alone or stand…

Matched conditions: REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

Phase: NA • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control

Last updated May 26, 2026 11:53 UTC

REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

Get alerted when new REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY trials appear

New hope for stubborn nerve disorder? drug combo tested in 76 patients